COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1326: Articles 13251-13260  | Next

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., Patalon, T.
10.1101/2021.08.24.21262415 — Posted: 2021-08-25 Discussion: Onsite | Offsite
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Servellita, V., Morris, M.-K., Sotomayor-Gonzalez, A., Gliwa, A., Torres, E., Brazer, N., Zhou, A., Hernandez, K., Sankaran, M., Wang, B., Wong, D., Wang, C., Zhang, Y., Reyes, K., Glasner, D., Deng, W., Streithorst, J., Miller, S., Frias, E., Hackett, J., Hanson, C., Wadford, D. A., Philip, S., Topper, S., Sachdev, D., Chiu, C. Y.
10.1101/2021.08.19.21262139 — Posted: 2021-08-25 Discussion: Onsite
Evaluation of the relationship between quantitative PCR results and cell culturing of SARS2-CoV with respect to symptoms onset and Viral load - a systematic review
rozenberg, g., Erster, O., Ghersin, I., Mandelboim, M., neuberger, A., Schwartz, E.
10.1101/2021.08.23.21262162 — Posted: 2021-08-25
SARS-CoV-2 susceptibility and ACE2 gene variations within diverse ethnic backgrounds
Vadgama, N., Kreymerman, A., Campbell, J., Shamardina, O., Brugger, C., Genomics England Research Consortium, , Lee, R. T., Penkett, C. J., Gifford, C. A., Mercola, M., Nasir, J., Karakikes, I.
10.1101/2021.08.18.21261804 — Posted: 2021-08-25
The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19).
Cerqueira-Silva, T., Oliveira, V. d. A., Pescarini, J., Bertoldo Junior, J., Machado, T. M., Ortiz, R. F., Penna, G., Ichihara, M. Y., Venancio de Barros, J., Boaventura, V., Barreto, M. L., Werneck, G. L., Barral-Netto, M.
10.1101/2021.08.21.21261501 — Posted: 2021-08-25 Discussion: Onsite
Temporal Increase in Neutralization Potency of SARS-CoV-2 Antibodies and Reduced Viral Variant Escape after Sputnik V Vaccination
Gonzalez Lopez Ledesma, M. M., Sanchez, L., Ojeda, D. S., Oviedo Rouco, S., Rossi, A. H., Varesse, A., Mazzitelli, I., Pascuale, C. A., Miglietta, E. A., Rodriguez, P. E., Pallares, H. M., Costa Navarro, G. S., Caramelo, J. J., Rothlauf, P. W., Liu, Z., Bloyet, L.-M., Cornejo Pontelli, M., Rasetto, N. B., Wenker, S. D., Ramis, L. Y., Bialer, M. G., de Leone, M. J., Hernando, C. E., Bianchamino, L., Rios, A., Treffinger Cienfuegos, M. S., Rodriguez Garcia, D. R., Longueira, Y., Laufer, N., Alvarez, D., Ceballos, A., Ocho, V., Monzani, C., Turk, G., Salvatori, M., Carradori, J., Prost, K., Rima, A., Varela, C., Ercole, R., Toro, R. I., Gutierrez, S., Zubieta, M., Acuna, D., Nabaes Jodar, M. S., Torres, C., Mojsiejczuk, L., Viegas, M., Velazquez, P., Testa, C., Kreplak, N., Yanovsky, M., Whelan, S., Geffner, J., Pifano, M., Gamarnik, A. V.
10.1101/2021.08.22.21262186 — Posted: 2021-08-25 Discussion: Onsite
A Lagrangian Approach Towards Quantitative Analysis Of Flow-mediated Infection Transmission In Indoor Spaces With Application To SARS-COV-2
Wilson, J., Miller, S. L., Mukherjee, D.
10.1101/2021.08.22.21262447 — Posted: 2021-08-25
All-cause excess mortality in the State of Gujarat, India, during the COVID-19 pandemic (March 2020-April 2021)
Acosta, R. J., Patnaik, B., Buckee, C., Balsari, S., Mahmud, A.
10.1101/2021.08.22.21262432 — Posted: 2021-08-25
Defective ORF8 dimerization in delta variant of SARS CoV2 leads to abrogation of ORF8 MHC-I interaction and overcome suppression of adaptive immune response
Chaudhari, A., Singh, D. I., Joshi, D. M., PATEL, D. A., Joshi, P. C.
10.1101/2021.08.24.457457 — Posted: 2021-08-24
Immunization with SARS-CoV-2 nucleocapsid protein triggers a pulmonary immune response in rats
Silva, E. K. V. B., Bomfim, C. G., Barbosa, A. P., Noda, P., Noronha, I. L., Fernandes, B. H. V., Machado, R. R. G., Durigon, E. L., Catanozi, S., Rodrigues, L. G., Pieroni, F., Lima, S., Queiroz, Z. A. J., Charlie-Silva, I., Silveira, L. K. R., Teodoro, W. T., Capelozzi, V. L., Guzzo, C. R., Fanelli, C.
10.1101/2021.08.24.457520 — Posted: 2021-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).